Azienda Socio Sanitaria Territoriale Della Valtellina E Dell Alto Lario

Sondrio 11 trials 5 recruiting

11 Registered trials

5 Currently recruiting

Organisation

Azienda Socio Sanitaria Territoriale Della Valtellina E Dell Alto Lario

Location

Sondrio, Italy

Identifier

ORG-100046055

Address

Via Stelvio N 25, 23100, Italy

Departments

4105: Oncologia Medica
medical oncology
Medicina Interna
Oncologia Medica
Oncologia Medica - Ospedale di Sondrio
Radiotherapy
S.C. Oncologia Medica
SC Oncologia Medica
U.O. medicina Generale

Clinical trials at this site (11)

Search interface

Use of Sulodexide (VESSEL®) for the prevention of a new episode in elderly patients who have had a first episode of deep vein thrombosis and… Pending

2024-517796-21-00 Prevention of recurrence after a first episode of Venou 5
Stereotactic body radiation therapy on Prostate with or without Androgen deprivation therapy, a phase III randomized controlled trial (SPA T… Pending

2024-520093-34-00 Acinar cell prostatic carcinoma 5
Comparison between ABP 234 and Keytruda® (Pembrolizumab) Recruiting

2024-514304-14-00 Advanced or Metastatic Non-squamous Non-Small Cell Lung 1 2024-10-08
Phase III trial comparing local radiotherapy alone or with Obinutuzumab in early stage Follicular Lymphoma: the GAZEBO Trial. Recruiting

2022-502775-29-01 Early stage Follicular Lymphoma 5 2023-12-14
A study of tucatinib with trastuzumab and mFOLFOX6 versus standard of care treatment in first-line HER2+ metastatic colorectal cancer Recruiting

2024-514180-25-00 unresectable or metastatic HER2+ colorectal cancer 5 2022-11-21
Evaluation of an initial treatment with bevacizumab in combination with chemotherapy and then in combination with niraparib in maintenance i… Recruiting

2023-504166-37-00 Advanced ovarian, tubal or peritoneal cancer. 4 2022-02-01
NeoAspMet - Neoadjuvant Aspirin and/or Metformin during preoperative induction chemotherapy and chemoradiotherapy for locally-advanced recta… Recruiting

2024-519007-10-00 Locally advanced stage II/III rectal cancer 10 2020-10-22
An open-label, single-arm, Phase II, multinational, multicentre study to assess the efficacy and safety of 5 years of osimertinib in partici… Ended

2023-508740-21-00 Non-Small Cell Lung Cancer 4 2023-02-15
Phase II study to evaluate diarrhoea discontinuations at 3 cycles in patients with early-stage HER2 positive, hormone receptor positive brea… Ended

2024-514630-21-00 HER2 positive (HER2+), Hormone Receptor positive (HR+) 4 2022-08-11
Shortened vs standard chemotherapy combined with immunotherapy for the initial treatment of patients with high tumor burden Follicular Lymph… Ended

2024-511636-27-00 Follicular Lymphoma 5 2021-12-01
eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients Ended

2024-513454-29-00 Non-Small Cell Lung Cancer (NSCLC) 5 2015-10-15